Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit

On September 2, 2020 Targovax ASA, reported that members of its senior management team is invited to present at upcoming conferences (Press release, Targovax, SEP 2, 2020, View Source [SID1234564242]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pareto Securities’ 11th Annual Health Care Conference 2020, virtual
Date: 2 September 2020
Presenter: Torbjørn Furuseth (CFO)

Presentation:
– Time: 11:30 CET

2nd Annual RAS-Targeted Drug development summit, virtual
Date: 15 September 2020
Presenter: Erik Digman Wiklund (CBO)

Presentation:
Title: Adopting a Polyvalent Approach to Aid Development of Vaccines Against Mutant RAS
Time: 15:40 EDT / 21:40 CET

Panel discussion:
Live Q&A Panel
Time: 16:10 EDT / 22:10 CET

Presentations will be available to download at www.targovax.com after the event.